{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T11:09:49Z","timestamp":1777460989918,"version":"3.51.4"},"reference-count":45,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2021,6,29]],"date-time":"2021-06-29T00:00:00Z","timestamp":1624924800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Cure Juvenile Myositis Foundation"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,4,11]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Objectives<\/jats:title>\n                  <jats:p>To perform an exploratory study to identify a JDM serum metabolic profile that differs from healthy controls (HCs) and responds to immunosuppressive treatment.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Blood was collected from 9 HCs and 10 patients diagnosed with probable (n\u2009=\u20094) or definite (n\u2009=\u20096) JDM based on the criteria of Bohan and Peter for myositis, with 7 of the 10 providing longitudinal samples following initiation of treatment; these patients comprised the treatment-na\u00efve cohort. Sera underwent mass spectroscopy\u2013based measurements of targeted metabolic intermediates, including 15 amino acids, 45 acylcarnitines (ACs), 15 ceramides and 29 sphingomyelins. Principal components analysis reduced metabolites into smaller sets of factors each comprised of correlated metabolic intermediates. Factor scores and metabolite concentrations were compared with HCs using two-sample t-tests while treatment effects were evaluated using paired t-tests.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Of eight principal components analysis\u2013derived metabolite factors (one AC, two amino acids, three sphingosine and two ceramide), two were significantly associated with JDM: one AC factor containing mostly long-chain ACs (P\u2009=\u20090.049) and one ceramide factor (P\u2009&amp;lt;\u20090.01). For 12 individual ACs, mostly long chain, and three ceramides, concentrations were significantly greater for JDM than HCs. Factors based on these individual metabolites showed decreasing scores with treatment (P\u2009=\u20090.03 and P\u2009&amp;lt;\u20090.01, respectively).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>While additional validation is needed, these lipids have potential as JDM serum diagnostic and\/or treatment biomarkers. Additionally, the significant association of long-chain ACs and ceramides with JDM offers insights regarding pathogenesis, implicating dysregulation of mitochondrial fatty acid \u03b2-oxidation.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/rheumatology\/keab520","type":"journal-article","created":{"date-parts":[[2021,6,26]],"date-time":"2021-06-26T19:10:10Z","timestamp":1624734610000},"page":"1699-1708","source":"Crossref","is-referenced-by-count":9,"title":["Metabolomics analysis identifies a lipidomic profile in treatment-na\u00efve juvenile dermatomyositis patients <i>vs<\/i> healthy control subjects"],"prefix":"10.1093","volume":"61","author":[{"given":"Jeffrey A","family":"Dvergsten","sequence":"first","affiliation":[{"name":"Department of Pediatrics, Duke Children\u2019s Hospital, Duke University Medical Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ann M","family":"Reed","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Duke Children\u2019s Hospital, Duke University Medical Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lawrence","family":"Landerman","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Duke Children\u2019s Hospital, Duke University Medical Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David S","family":"Pisetsky","sequence":"additional","affiliation":[{"name":"Department of Medicine and Immunology, Duke University Medical Center and Research Service, Durham VA Medical Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olga","family":"Ilkayeva","sequence":"additional","affiliation":[{"name":"Department of Medicine, Duke Molecular Physiology Institute, Duke School of Medicine, Durham, NC, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kim M","family":"Huffman","sequence":"additional","affiliation":[{"name":"Department of Medicine, Duke Molecular Physiology Institute, Duke School of Medicine, Durham, NC, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2021,6,29]]},"reference":[{"key":"2022041112502166600_keab520-B1","doi-asserted-by":"crossref","first-page":"2201","DOI":"10.1016\/S0140-6736(08)60955-1","article-title":"Juvenile dermatomyositis and other idiopathic inflammatory myopathies of childhood","volume":"371","author":"Feldman","year":"2008","journal-title":"Lancet"},{"key":"2022041112502166600_keab520-B2","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.berh.2017.12.003","article-title":"Juvenile dermatomyositis: latest advances","volume":"31","author":"Wu","year":"2017","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"2022041112502166600_keab520-B3","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.rdc.2011.01.002","article-title":"Polymyositis and dermatomyositis: pathophysiology","volume":"37","author":"Nagaraju","year":"2011","journal-title":"Rheum Dis Clin N Am"},{"key":"2022041112502166600_keab520-B4","doi-asserted-by":"crossref","first-page":"2951","DOI":"10.3389\/fimmu.2018.02951","article-title":"Systemic and tissue inflammation in juvenile dermatomyositis: from pathogenesis to the quest for monitoring tools","volume":"9","author":"Wienke","year":"2018","journal-title":"Front Immunol"},{"key":"2022041112502166600_keab520-B5","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/s11154-014-9296-6","article-title":"Skeletal muscle glucose metabolism and inflammation in the development of the metabolic syndrome","volume":"15","author":"Marette","year":"2014","journal-title":"Rev Endocr Metab Disord"},{"key":"2022041112502166600_keab520-B6","first-page":"1993","article-title":"Skeletal muscle fuel selection occurs at the mitochondrial level","volume":"217","author":"Kuzmiak-Glancy","year":"2014","journal-title":"J Exp Biol"},{"key":"2022041112502166600_keab520-B7","doi-asserted-by":"crossref","first-page":"8152","DOI":"10.1002\/jcp.27603","article-title":"Insulin resistance: review of the underlying molecular mechanisms","volume":"234","author":"Yaribeygi","year":"2019","journal-title":"J Cell Physiol"},{"key":"2022041112502166600_keab520-B8","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1002\/(SICI)1099-1492(199806\/08)11:4\/5<245::AID-NBM513>3.0.CO;2-4","article-title":"Analysis of 31P MR spectroscopy data using artificial neural networks for longitudinal evaluation of muscle disease: dermatomyositis","volume":"11","author":"Park","year":"1998","journal-title":"NMR Biomed"},{"key":"2022041112502166600_keab520-B9","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1002\/1529-0131(200010)43:10<2359::AID-ANR25>3.0.CO;2-D","article-title":"Muscle abnormalities in juvenile myositis patients","volume":"43","author":"Park","year":"2000","journal-title":"Arthritis Rheum"},{"key":"2022041112502166600_keab520-B10","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1002\/art.21331","article-title":"Muscle metabolites, detected in urine by proton spectroscopy, correlate with disease damage in juvenile idiopathic inflammatory myopathies","volume":"53","author":"Chung","year":"2005","journal-title":"Arthritis Rheum"},{"key":"2022041112502166600_keab520-B11","doi-asserted-by":"crossref","first-page":"4781","DOI":"10.3390\/ijms20194781","article-title":"The need for multi-omics biomarker signatures in precision medicine","volume":"20","author":"Olivier","year":"2019","journal-title":"Int J Mol Sci"},{"key":"2022041112502166600_keab520-B12","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1039\/C6MB00656F","article-title":"Mass spectrometry for the discovery of biomarkers of sepsis","volume":"13","author":"Ludwig","year":"2017","journal-title":"Mol Biosyst"},{"key":"2022041112502166600_keab520-B13","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1097\/GIM.0b013e3181614289","article-title":"Acylcarnitine profile analysis","volume":"10","author":"Rinaldo","year":"2008","journal-title":"Genet Med"},{"key":"2022041112502166600_keab520-B14","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1038\/gene.2015.28","article-title":"Genome-wide association study identifies HLA 8.1 ancestral haplotype alleles as major genetic risk factors for myositis phenotypes","volume":"16","author":"Miller","year":"2015","journal-title":"Genes Immun"},{"key":"2022041112502166600_keab520-B15","doi-asserted-by":"crossref","first-page":"3436","DOI":"10.1002\/art.24936","article-title":"Interleukin-6 and type I interferon-regulated genes and chemokines mark disease activity in dermatomyositis","volume":"60","author":"Bilgic","year":"2009","journal-title":"Arthritis Rheum"},{"key":"2022041112502166600_keab520-B16","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1002\/art.40881","article-title":"Galectin-9 and CXCL-10 as biomarkers for disease activity in juvenile dermatomyositis: a longitudinal cohort study and multicohort validation","volume":"71","author":"Wienke","year":"2019","journal-title":"Arthritis Rheum"},{"key":"2022041112502166600_keab520-B17","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1096\/fj.14-255901","article-title":"Acylcarnitines: potential implications for skeletal muscle insulin resistance","volume":"29","author":"Aguer","year":"2015","journal-title":"FASEB J"},{"key":"2022041112502166600_keab520-B18","doi-asserted-by":"crossref","first-page":"H768","DOI":"10.1152\/ajpheart.00820.2016","article-title":"Circulating acylcarnitine profile in human heart failure: a surrogate of fatty acid metabolic dysregulation in mitochondria and beyond","volume":"313","author":"Ruiz","year":"2017","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"2022041112502166600_keab520-B19","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1093\/gerona\/glw031","article-title":"Association of plasma small-molecule intermediate metabolites with age and body mass index across six diverse study populations","volume":"71","author":"Kraus","year":"2016","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"2022041112502166600_keab520-B20","doi-asserted-by":"crossref","first-page":"e003190","DOI":"10.1161\/JAHA.115.003190","article-title":"Metabolomic profiling identifies novel circulating biomarkers of mitochondrial dysfunction differentially elevated in heart failure with preserved versus reduced ejection fraction: evidence for shared metabolic impairments in clinical heart failure","volume":"5","author":"Hunter","year":"2016","journal-title":"J Am Heart Assoc"},{"key":"2022041112502166600_keab520-B21","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/nrrheum.2016.1","article-title":"Metabolomics in rheumatic disease: desperately seeking biomarkers","volume":"12","author":"Guma","year":"2016","journal-title":"Nat Rev Rheumatol"},{"key":"2022041112502166600_keab520-B22","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/s13075-018-1579-y","article-title":"Targeted lipidomics analysis identified altered serum lipid profiles in patients with polymyositis and dermatomyositis","volume":"20","author":"Raouf","year":"2018","journal-title":"Arthritis Res Ther"},{"key":"2022041112502166600_keab520-B23","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1056\/NEJM197502132920706","article-title":"Polymyositis and dermatomyositis","volume":"292","author":"Bohan","year":"1975","journal-title":"N Engl J Med"},{"key":"2022041112502166600_keab520-B24","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1038\/nm995","article-title":"Hepatic expression of malonyl-CoA decarboxylase reverses muscle, liver and whole-animal insulin resistance","volume":"10","author":"An","year":"2004","journal-title":"Nat Med"},{"key":"2022041112502166600_keab520-B25","doi-asserted-by":"crossref","first-page":"e1000034","DOI":"10.1371\/journal.pgen.1000034","article-title":"Genetic networks of liver metabolism revealed by integration of metabolic and transcriptional profiling","volume":"4","author":"Ferrara","year":"2008","journal-title":"PLoS Genet"},{"key":"2022041112502166600_keab520-B26","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.ymeth.2005.01.009","article-title":"Sphingolipodomics: high-throughput, structure-specific, and quantitative analysis of sphingolipids by liquid chromatography tandem mass spectrometry","volume":"36","author":"Merrill","year":"2005","journal-title":"Methods"},{"key":"2022041112502166600_keab520-B27","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.2337\/dc08-2075","article-title":"Relationships between circulating metabolic intermediates and insulin action in overweight to obese, inactive men and women","volume":"32","author":"Huffman","year":"2009","journal-title":"Diabetes Care"},{"key":"2022041112502166600_keab520-B28","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/joim.12444","article-title":"The juvenile idiopathic inflammatory myopathies: pathogenesis, clinical and autoantibody phenotypes, and outcomes","volume":"280","author":"Rider","year":"2016","journal-title":"J Intern Med"},{"key":"2022041112502166600_keab520-B29","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.jaut.2017.06.007","article-title":"Autoantibodies in juvenile-onset myositis: their diagnostic value and associated clinical phenotype in a large UK cohort","volume":"84","author":"Tansley","year":"2017","journal-title":"J Autoimmun"},{"key":"2022041112502166600_keab520-B30","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.cmet.2012.04.010","article-title":"Lipid-induced mitochondrial stress and insulin action in muscle","volume":"15","author":"Muoio","year":"2012","journal-title":"Cell Metab"},{"key":"2022041112502166600_keab520-B31","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.bbalip.2011.06.009","article-title":"Lipid classification, structures and tools","volume":"1811","author":"Fahy","year":"2011","journal-title":"Biochim Biophys Acta"},{"key":"2022041112502166600_keab520-B32","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1038\/nrendo.2015.129","article-title":"Acylcarnitines\u2014old actors auditioning for new roles in metabolic physiology","volume":"11","author":"McCoin","year":"2015","journal-title":"Nat Rev Endocrinol"},{"key":"2022041112502166600_keab520-B33","doi-asserted-by":"crossref","first-page":"e12977","DOI":"10.14814\/phy2.12977","article-title":"Plasma acylcarnitine profiling indicates increased fatty acid oxidation relative to tricarboxylic acid cycle capacity in young, healthy low birth weight men","volume":"4","author":"Ribel-Madsen","year":"2016","journal-title":"Physiol Rep"},{"key":"2022041112502166600_keab520-B34","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.mito.2018.02.009","article-title":"Mitochondrial \u03b2-oxidation of saturated fatty acids in humans","volume":"46","author":"Adeva-Andany","year":"2019","journal-title":"Mitochondrion"},{"key":"2022041112502166600_keab520-B35","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1111\/j.1742-4658.2010.07947.x","article-title":"Fatty acid omega-oxidation as a rescue pathway for fatty acid oxidation disorders in humans","volume":"278","author":"Wanders","year":"2011","journal-title":"FEBS J"},{"key":"2022041112502166600_keab520-B36","doi-asserted-by":"crossref","first-page":"7588","DOI":"10.1074\/jbc.M117.785345","article-title":"Regulation of very-long chain acyl chain ceramide synthesis by acyl-CoA-binding protein","volume":"292","author":"Ferreira","year":"2017","journal-title":"J Biol Chem"},{"key":"2022041112502166600_keab520-B37","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.febslet.2007.11.057","article-title":"Inflammation and insulin resistance","volume":"582","author":"de Luca","year":"2008","journal-title":"FEBS Lett"},{"key":"2022041112502166600_keab520-B38","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.physbeh.2007.11.049","article-title":"Lipid accumulation in non-adipose tissue and lipotoxicity","volume":"94","author":"van Herpen","year":"2008","journal-title":"Physiol Behav"},{"key":"2022041112502166600_keab520-B39","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1194\/jlr.R067595","article-title":"The role of ER stress in lipid metabolism and lipotoxicity","volume":"57","author":"Han","year":"2016","journal-title":"J Lipid Res"},{"key":"2022041112502166600_keab520-B40","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1186\/s12944-019-1145-x","article-title":"Angiotensin-converting enzyme 2 regulates endoplasmic reticulum stress and mitochondrial function to preserve skeletal muscle lipid metabolism","volume":"18","author":"Cao","year":"2019","journal-title":"Lipids Health Dis"},{"key":"2022041112502166600_keab520-B41","doi-asserted-by":"crossref","first-page":"4078","DOI":"10.1002\/art.34659","article-title":"Changes in novel biomarkers of disease activity in juvenile and adult dermatomyositis are sensitive biomarkers of disease course","volume":"64","author":"Reed","year":"2012","journal-title":"Arthritis Rheum"},{"key":"2022041112502166600_keab520-B42","doi-asserted-by":"crossref","first-page":"103243","DOI":"10.1016\/j.ebiom.2021.103243","article-title":"Increased apolipoprotein-B:A1 ratio predicts cardiometabolic risk in patients with juvenile onset SLE","volume":"65","author":"Robinson","year":"2021","journal-title":"EBiomedicine"},{"key":"2022041112502166600_keab520-B43","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.coi.2017.04.010","article-title":"Metabolic signatures of T-cells and macrophages in rheumatoid arthritis","volume":"46","author":"Weyand","year":"2017","journal-title":"Curr Opin Immunol"},{"key":"2022041112502166600_keab520-B44","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/gm395","article-title":"Assessing the metabolic effects of prednisolone in healthy volunteers using urine metabolic profiling","volume":"4","author":"Ellero-Simatos","year":"2012","journal-title":"Genome Med"},{"key":"2022041112502166600_keab520-B45","first-page":"1259"}],"container-title":["Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/rheumatology\/advance-article-pdf\/doi\/10.1093\/rheumatology\/keab520\/40257333\/keab520.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/61\/4\/1699\/43356038\/keab520.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/61\/4\/1699\/43356038\/keab520.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,11]],"date-time":"2022-04-11T12:54:17Z","timestamp":1649681657000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumatology\/article\/61\/4\/1699\/6311284"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,29]]},"references-count":45,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2021,6,29]]},"published-print":{"date-parts":[[2022,4,11]]}},"URL":"https:\/\/doi.org\/10.1093\/rheumatology\/keab520","relation":{},"ISSN":["1462-0324","1462-0332"],"issn-type":[{"value":"1462-0324","type":"print"},{"value":"1462-0332","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,4,1]]},"published":{"date-parts":[[2021,6,29]]}}}